Drug profile · INN
naproxen sodium
NAPROXEN SODIUM
naproxen sodium (NAPROXEN SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — naproxen sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 7
- Data quality
- 0.89
Quick answer
naproxen sodium (NAPROXEN SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is naproxen sodium?
naproxen sodium (NAPROXEN SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naproxen sodium?
NAPROXEN SODIUM is a marketed brand name for naproxen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naproxen sodium?
naproxen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.